SV, J., & NS, R. (2015). Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? Dove Medical Press.
Style de citation Chicago (17e éd.)SV, Janardhan, et Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.
Style de citation MLA (8e éd.)SV, Janardhan, et Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.